Amarin (AMRN) News Today

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Analysts at Zacks Research raised their Q3 2024 earnings per share estimates for Amarin in a research report issued on Wednesday, August 21st. Zacks Research analyst R. Department now expects that the biopharmaceutical company will earn ($0.05) per sha

Amarin Co. plc (NASDAQ:AMRN - Get Free Report) CEO Aaron Berg acquired 160,000 shares of the stock in a transaction dated Friday, August 2nd. The shares were purchased at an average price of $0.64 per share, for a total transaction of $102,400.00. Following the completion of the transaction, the chief executive officer now owns 805,380 shares of the company's stock, valued at approximately $515,443.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Research analysts at Cantor Fitzgerald lifted their FY2024 earnings per share estimates for Amarin in a report issued on Thursday, August 1st. Cantor Fitzgerald analyst L. Chen now expects that the biopharmaceutical company will earn ($0.13) per share

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Analysts at Zacks Research reduced their FY2026 earnings per share (EPS) estimates for shares of Amarin in a report released on Tuesday, July 30th. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post earnin

Amarin Co. plc (NASDAQ:AMRN - Get Free Report) was the recipient of unusually large options trading on Monday. Stock investors bought 2,899 call options on the stock. This is an increase of approximately 399% compared to the typical volume of 581 call options.

StockNews.com downgraded shares of Amarin from a "buy" rating to a "hold" rating in a research note on Thursday.

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Investment analysts at Zacks Research lowered their Q3 2025 EPS estimates for shares of Amarin in a research note issued on Wednesday, June 26th. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post earnings

Amarin Co. plc (NASDAQ:AMRN - Get Free Report) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 19,020,000 shares, a growth of 20.3% from the May 31st total of 15,810,000 shares. Based on an average trading volume of 1,490,000 shares, the short-interest ratio is currently 12.8 days.

StockNews.com downgraded Amarin from a "buy" rating to a "hold" rating in a research note on Tuesday.

Cantor Fitzgerald reissued an "overweight" rating on shares of Amarin in a research report on Tuesday.

StockNews.com upgraded shares of Amarin from a "hold" rating to a "buy" rating in a research report on Monday.

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Zacks Research lifted their FY2024 earnings estimates for Amarin in a research report issued on Wednesday, May 22nd. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post earnings of ($0.16) per share for the

Amarin Co. plc (NASDAQ:AMRN - Free Report) - Research analysts at Zacks Research lowered their Q2 2025 EPS estimates for shares of Amarin in a research report issued to clients and investors on Tuesday, April 30th. Zacks Research analyst R. Department now expects that the biopharmaceutical compan

Amarin (NASDAQ:AMRN - Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02. The firm had revenue of $56.52 million during the quarter, compared to analyst estimates of $51.34 million. Amarin had a negative return on equity of 10.47% and a negative net margin of 19.26%. During the same period in the previous year, the company posted ($0.04) EPS.

Amarin Co. plc (NASDAQ:AMRN - Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 15,840,000 shares, a drop of 12.1% from the March 31st total of 18,020,000 shares. Based on an average daily trading volume, of 1,680,000 shares, the days-to-cover ratio is presently 9.4 days.